HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Panel To Consider Re-Reviewing AHA Safety As Use Rises

This article was originally published in The Rose Sheet

Executive Summary

With use of alpha hydroxy acids in personal-care products on the upswing, the Cosmetic Ingredient Review Expert Panel will revisit the ingredient group’s safety report and consider re-opening a review at its next meeting.

You may also be interested in...



CIR Affirms Previous AHA Conclusions, Issues Seven Final Safety Reports

A 1998 safety assessment for alpha hydroxy acids holds up despite an increase in ingredient use and concentration, the Cosmetic Ingredient Review Expert Panel said at its Dec. 9 meeting.

CIR Panel Affirms Paraben Safety, Will Investigate Infant Skin Properties

With parabens’ use in infant products coming under scrutiny abroad, the CIR Expert Panel intends to learn more about how infant skin reacts to personal-care products. However, the panel maintains its 2006 “safe as used” assessment for parabens.

FDA Final Guidance On AHAs Clarifies “Sunburn Alert” Labeling

FDA is modifying recommendations for which alpha hydroxy acid-containing cosmetics should carry "Sunburn Alert" labeling to include products that may be applied unintentionally to areas of the body that are exposed to sun, such as those that contain fragrance ingredients, humectants and skin conditioning agents

Related Content

Latest News
See All
UsernamePublicRestriction

Register

RS018836

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel